Evidence map›Paper›PMID 40274621›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Research mechanism of DBP and DEHP in the development of PCOS based on network toxicology and molecular docking.

Kang Yi-Fan, Liu Jian-Rong

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kang Yi-FanThe Fifth Clinical Medical College of Shanxi Medical University, Shanxi Provincial People's Hospital , Taiyuan, 030001, China.
Liu Jian-RongShanxi Provincial People's Hospital, Taiyuan, 030001, China. liujianrong3@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polycystic ovary syndrome (PCOS) constitutes a prevalent endocrine disorder among females, exhibiting a significant incidence rate. The etiology of PCOS predominantly attributes to environmental determinants. Phthalate esters, including dibutyl phthalate (DBP) and di(2-ethylhexyl) phthalate (DEHP), have been demonstrated to exert detrimental effects on reproductive function. However, the effects of these plasticizers on female reproductive health have not been clearly investigated. In the present investigation, we employed network toxicological methodologies to delineate the pivotal genes and associated pathways that are implicated in the pathogenesis of PCOS induced by DBP and DEHP. Molecular docking methodologies were employed to ascertain the interaction between the investigational compound and the designated target protein. The present study delineates pivotal targets, namely AKT1, SRC, PIK3R1, EGFR, ESR1, and STAT3, which are instrumental in the mediation of PCOS. The genes predominantly participate in the EGFR pathway, insulin signaling pathway, and oocyte damage, significantly compromising female ovarian functionality. This investigation underscores the integration of network toxicology, molecular docking, and cell experiment methodologies to elucidate the toxicological properties and underlying molecular mechanisms of plasticizers in the context of PCOS. This study provides a prospective therapeutic target to mitigate the harmful effects of plasticizers on female reproductive health.

Indexed as

Dibutyl PhthalateDiethylhexyl PhthalatePlasticizersPolycystic Ovary SyndromeErbB ReceptorsEstrogen Receptor alphaFemaleHumansMolecular Docking SimulationSignal TransductionDibutyl PhthalateDiethylhexyl PhthalateErbB ReceptorsEstrogen Receptor alphaPlasticizersDBPDEHPMolecular dockingNetwork toxicologyPCOS

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.